KMDA
Price
$7.88
Change
+$0.14 (+1.81%)
Updated
Jul 3 closing price
Capitalization
306.49M
39 days until earnings call
LFCR
Price
$8.04
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
176.87M
53 days until earnings call
Interact to see
Advertisement

KMDA vs LFCR

Header iconKMDA vs LFCR Comparison
Open Charts KMDA vs LFCRBanner chart's image
Kamada
Price$7.88
Change+$0.14 (+1.81%)
Volume$23.33K
Capitalization306.49M
Lifecore Biomedical
Price$8.04
Change-$0.00 (-0.00%)
Volume$55.72K
Capitalization176.87M
KMDA vs LFCR Comparison Chart in %
Loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KMDA vs. LFCR commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMDA is a StrongBuy and LFCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (KMDA: $7.88 vs. LFCR: $8.04)
Brand notoriety: KMDA and LFCR are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KMDA: 31% vs. LFCR: 23%
Market capitalization -- KMDA: $306.49M vs. LFCR: $176.87M
KMDA [@Pharmaceuticals: Other] is valued at $306.49M. LFCR’s [@Pharmaceuticals: Other] market capitalization is $176.87M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMDA’s FA Score shows that 1 FA rating(s) are green whileLFCR’s FA Score has 1 green FA rating(s).

  • KMDA’s FA Score: 1 green, 4 red.
  • LFCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both KMDA and LFCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 4 TA indicator(s) are bullish while LFCR’s TA Score has 4 bullish TA indicator(s).

  • KMDA’s TA Score: 4 bullish, 4 bearish.
  • LFCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both KMDA and LFCR are a good buy in the short-term.

Price Growth

KMDA (@Pharmaceuticals: Other) experienced а -0.25% price change this week, while LFCR (@Pharmaceuticals: Other) price change was -2.31% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

KMDA is expected to report earnings on Aug 13, 2025.

LFCR is expected to report earnings on Oct 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KMDA($306M) has a higher market cap than LFCR($177M). KMDA YTD gains are higher at: 33.100 vs. LFCR (8.210). KMDA has higher annual earnings (EBITDA): 22.4M vs. LFCR (-22.64M). KMDA has more cash in the bank: 55.6M vs. LFCR (4.22M). KMDA has less debt than LFCR: KMDA (8.82M) vs LFCR (157M). LFCR has higher revenues than KMDA: LFCR (188M) vs KMDA (143M).
KMDALFCRKMDA / LFCR
Capitalization306M177M173%
EBITDA22.4M-22.64M-99%
Gain YTD33.1008.210403%
P/E Ratio37.43N/A-
Revenue143M188M76%
Total Cash55.6M4.22M1,317%
Total Debt8.82M157M6%
FUNDAMENTALS RATINGS
KMDA vs LFCR: Fundamental Ratings
KMDA
LFCR
OUTLOOK RATING
1..100
1361
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
80100
PRICE GROWTH RATING
1..100
4039
P/E GROWTH RATING
1..100
285
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KMDA's Valuation (73) in the Biotechnology industry is in the same range as LFCR (93) in the Industrial Specialties industry. This means that KMDA’s stock grew similarly to LFCR’s over the last 12 months.

KMDA's Profit vs Risk Rating (98) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that KMDA’s stock grew similarly to LFCR’s over the last 12 months.

KMDA's SMR Rating (80) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that KMDA’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's Price Growth Rating (39) in the Industrial Specialties industry is in the same range as KMDA (40) in the Biotechnology industry. This means that LFCR’s stock grew similarly to KMDA’s over the last 12 months.

LFCR's P/E Growth Rating (5) in the Industrial Specialties industry is in the same range as KMDA (28) in the Biotechnology industry. This means that LFCR’s stock grew similarly to KMDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KMDALFCR
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
66%
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 22 days ago
67%
Bearish Trend 4 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTSKF49.50N/A
N/A
Otsuka Holdings Co. Ltd.
WNDLF97.73N/A
N/A
Wendel
ASAGF0.92N/A
N/A
Australian Agricultural Co Ltd.
HWKE0.14N/A
N/A
Hawkeye Systems, Inc.
QIFTF0.58N/A
N/A
Quorum Information Technologies Inc.

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and RDY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and RDY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
+1.81%
RDY - KMDA
32%
Poorly correlated
+1.34%
SGIOY - KMDA
27%
Poorly correlated
-2.15%
OGI - KMDA
26%
Poorly correlated
+3.62%
INCR - KMDA
26%
Poorly correlated
+5.41%
LFCR - KMDA
25%
Poorly correlated
N/A
More

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
N/A
SHPH - LFCR
31%
Poorly correlated
-1.51%
AMRX - LFCR
28%
Poorly correlated
+0.60%
OGI - LFCR
28%
Poorly correlated
+3.62%
ALKS - LFCR
27%
Poorly correlated
-0.52%
HROW - LFCR
27%
Poorly correlated
+3.86%
More